Flooding the market with sub-par seed can impact future uptake of improved seed varieties that are designed to boost productivity. If farmers cease to see any difference in performance between their local varieties and so-called improved varieties, there will be no incentive for them to purchase new [Read More]

Artemisinin monotherapy, which the WHO rejects as inherently substandard treatment even when its dosage is correct, remains common in Africa. [Read More]